Inventor · disambiguated record
Hye Jung Jang
Also filed as: JANG HYE JUNG
0 granted patents·2 pending applications·0 citations·filing 2020–2021
Technology areasA61K
Files withDAEWOONG PHARMACEUTICAL CO LTD2
Top patents by PatentIndex Score
2 records- 0152US2025073205A1Novel formulation for oral administration, comprising 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1h-pyrrol-3-yl)-n-methylmethanamineDAEWOONG PHARMACEUTICAL CO LTD·Filed 2021·Application pending·0 cites
- 0241US2022387476A1Liquid Pharmaceutical Composition of 1-(5-(2,4-difluorophenyl)-1-((3-fluorophenyl)sulfonyl)-4-methoxy-1H-pyrrol-3-yl)-N-methylmethanamineDAEWOONG PHARMACEUTICAL CO LTD·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Hye Jung Jang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →